Adiposogenital dystrophy epidemiology and demographics

	Adiposogenital dystrophy Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Adiposogenital dystrophy from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
Head X Ray
CT
MRI
Vision Test
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Adiposogenital dystrophy epidemiology and demographics On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Adiposogenital dystrophy epidemiology and demographics All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Adiposogenital dystrophy epidemiology and demographics
CDC on Adiposogenital dystrophy epidemiology and demographics
Adiposogenital dystrophy epidemiology and demographics in the news
Blogs on Adiposogenital dystrophy epidemiology and demographics
Directions to Hospitals Treating Adiposogenital dystrophy
Risk calculators and risk factors for Adiposogenital dystrophy epidemiology and demographics

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Ogechukwu Hannah Nnabude, MD

Overview

The prevalence of adiposogenital dystrophy is unknown.

The prevalence of adiposogenital dystrophy is currently unknown, however, it is more commonly seen in males^[1].

↑ Babinski-fröhlich syndrome. Bissonnette B, & Luginbuehl I, & Marciniak B, & Dalens B.J.(Eds.), (2006). Syndromes: Rapid Recognition and Perioperative Implications. McGraw Hill. https://accessanesthesiology.mhmedical.com/content.aspx?bookid=852&sectionid=49517244